36 results on '"Xia, Wenle"'
Search Results
2. Supplementary Data from An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity
3. Supplementary Figure S1 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
4. Supplementary Table S2 from Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
5. Luminescent Gold Nanoparticles with Controllable Hydrophobic Interactions
6. Activation of AMP-Activated Protein Kinase by Human EGF Receptor 2/EGF Receptor Tyrosine Kinase Inhibitor Protects Cardiac Cells
7. A Model of Acquired Autoresistance to a Potent ErbB2 Tyrosine Kinase Inhibitor and a Therapeutic Strategy to Prevent Its Onset in Breast Cancer
8. Combining lapatinib (GW572016), a small molecule inhibitor of ErbB1 and ErbB2 tyrosine kinases, with therapeutic anti-ErbB2 antibodies enhances apoptosis of ErbB2-overexpressing breast cancer cells
9. Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016
10. Concurrent Exposure to Heat Shock and H7 Synergizes to Trigger Breast Cancer Cell Apoptosis while Sparing Normal Cells
11. Anti-tumor activity of GW572016: a dual tyrosine kinase inhibitor blocks EGF activation of EGFR/erbB2 and downstream Erk1/2 and AKT pathways
12. Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo
13. Study of the Biologic Effects of Lapatinib, a Reversible Inhibitor of ErbB1 and ErbB2 Tyrosine Kinases, on Tumor Growth and Survival Pathways in Patients With Advanced Malignancies
14. A ratiometric detection of heparin with high sensitivity based on aggregation-enhanced emission of gold nanoclusters triggered by silicon nanoparticles
15. Tumor selective [G.sub.2]/M cell cycle arrest and apoptosis of epithelial and hematological malignancies by BBL22, a benzazepine
16. X-Ray Psoralen Activated Cancer Therapy (X-PACT)
17. Photo-Activated Psoralen Binds the ErbB2 Catalytic Kinase Domain, Blocking ErbB2 Signaling and Triggering Tumor Cell Apoptosis
18. An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models
19. Induction of autophagy across multiple tumor types through irreversible HER tyrosine kinase blockade.
20. A Network of Substrates of the E3 Ubiquitin Ligases MDM2 and HUWE1 Control Apoptosis Independently of p53
21. Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells
22. Truncated ErbB2 Expressed in Tumor Cell Nuclei Contributes to Acquired Therapeutic Resistance to ErbB2 Kinase Inhibitors
23. An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity
24. Resistance to ErbB2 Tyrosine Kinase Inhibitors in Breast Cancer Is Mediated by Calcium-Dependent Activation of RelA
25. Synergism from combined immunologic and pharmacologic inhibition of HER2in vivo
26. Acquired Resistance to Small Molecule ErbB2 Tyrosine Kinase Inhibitors
27. HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors
28. Lapatinib Antitumor Activity Is Not Dependent upon Phosphatase and Tensin Homologue Deleted on Chromosome 10 in ErbB2-Overexpressing Breast Cancers
29. Rational Development of Targeted Cancer Therapies Using Biomarkers
30. Regulation of Survivin by ErbB2 Signaling: Therapeutic Implications for ErbB2-Overexpressing Breast Cancers
31. Sensitization of tumor cells to Fas killing through overexpression of heat-shock transcription factor 1
32. Modulation of tolerance by mutant heat shock transcription factors
33. Transcriptional Activation of Heat Shock Factor HSF1 Probed by Phosphopeptide Analysis of Factor 32P-labeled in Vivo
34. Hyperphosphorylation of Heat Shock Transcription Factor 1 Is Correlated with Transcriptional Competence and Slow Dissociation of Active Factor Trimers
35. Affinity Chromatography of Regulatory Subunits of Protein Phosphatase-1
36. Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.